Search

Your search keyword '"Wappenschmidt B"' showing total 466 results

Search Constraints

Start Over You searched for: Author "Wappenschmidt B" Remove constraint Author: "Wappenschmidt B"
466 results on '"Wappenschmidt B"'

Search Results

1. A multi-centre international quality control study comparing mRNA splicing assay protocols and reporting practices from the ENIGMA consortium

3. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

4. Clinical, splicing and functional analysis to classify BRCA2 exon 3 variants

5. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

6. A Likelihood Ratio Approach for Utilizing Case-Control Data in the Clinical Classification of Rare Sequence Variants: Application to BRCA1 and BRCA2

7. FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women

8. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

9. Polygenic risk modeling for prediction of epithelial ovarian cancer risk (vol 30, pg 349, 2021)

10. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

11. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

12. Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants

13. Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study

15. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study

16. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

17. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature Communications, (2021), 12, 1, (1078), 10.1038/s41467-020-20496-3).

18. Erratum: Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature communications (2021) 12 1 (1078)).

19. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.

20. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

21. Characterization of the Cancer Spectrum in Men with Germline BRCA1 and BRCA2 Pathogenic Variants: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

22. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.

23. The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

24. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (vol 12, 1078, 2021)

25. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

26. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

31. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

32. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

33. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

34. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

35. Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness.

36. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

37. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.

38. Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer.

39. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

40. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

41. Implementation of an educational program and risk-adjusted prevention program for breast and ovarian cancer of the German Consortium for Hereditary Breast- and Ovarian Cancer

42. Knowledge-generating Care using the Example of hereditary Breast- and Ovarian Cancer (BC/OC): Evaluation of the comprehensive Care Concept

43. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

44. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

45. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

46. Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer

47. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

48. Wissen-generierende Versorgung am Beispiel des erblich bedingten Mamma- und Ovarialkarzinoms (BC/OC): Evaluation des flächendeckenden Versorgungskonzepts

49. Implementation of an educational program and risk-adjusted prevention program for breast and ovarian cancer of the German Consortium for Hereditary Breast- and Ovarian Cancer

Catalog

Books, media, physical & digital resources